Growing antimicrobial resistance is forcing Hyderabad hospitals to rely on expensive last-line antibiotics such as Fetroja (cefiderocol) to treat multidrug-resistant infections. Doctors warn that antibiotic misuse is fuelling superbugs, leaving patients with limited treatment options and treatment costs exceeding Rs 20 lakh.
